What are the guidelines for medication for children with congenital heart disease?

When it comes to congenital heart disease, many people feel at a loss when they find out their children have this disease. During the treatment process, many informal hospitals give children incorrect drugs, which has caused many children to be in danger of life due to improper use of drugs. So today we will talk to you about the medication guidelines for children with congenital heart disease.

Let us first look at what congenital heart disease is in children: Congenital heart disease is the most common type of congenital malformations, accounting for about 28% of all congenital malformations. It refers to anatomical abnormalities caused by formation disorders or developmental abnormalities of the heart and large blood vessels during embryonic development, or the failure of channels that should close automatically after birth to close (normal in the fetus).

So what are the medication guidelines for treating congenital heart disease in children? Let's take a look at it together:

1. Children with non-cyanotic congenital heart disease without pulmonary hypertension should take medication for one month after discharge to help restore heart function. If no abnormalities are found in the one-month follow-up examination, the medication can be stopped.

2. For children with non-cyanotic congenital heart disease and pulmonary hypertension, it is recommended to take medication for 3 months and bring medication for 1 month when discharged from the hospital. After taking the medication for 1 month, go to the hospital for a review of the medication situation, and adjust the dosage according to the recovery situation and continue the medication. During the review after 3 months, the medication can be reduced or continued according to the situation.

3. Children with cyanotic congenital heart disease recover more slowly after surgery than those with non-cyanotic congenital heart disease. They should take medication for at least 3 months and keep medication for 1 month after discharge. During the 1-month follow-up, the dosage can be adjusted appropriately according to the situation and medication can be continued. During the 3-month follow-up, medication can be reduced or stopped or continued according to the situation.

4. Children who have undergone bidirectional Glenn, total cavopulmonary connection, or systemic-pulmonary shunt surgery need low-dose aspirin after surgery and should not stop taking the medication without authorization. A professional doctor should be consulted on when to stop taking the medication.

However, the above are all the guidelines for postoperative medication. Because medication for congenital heart disease in children cannot be used as the main means of treatment, it can only be used as an auxiliary means of treatment. Therefore, you still have to go to a regular hospital to find out how to use the medication and follow the treatment plan given by an experienced and ethical doctor.